Syndecan-1 expression has prognostic significance in head and neck carcinoma

British Journal of Cancer

Volumn 79, Issue 3-4, 1999, Pages 558-564

  Anttonen, A ^a   Kajanti, M ^a   Heikkila P ^a   Jalkanen, M ^b   Joensuu, H ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

Author keywords

Head and neck cancer; Prognosis; Proteoglycan; Squamous cell carcinoma; Syndecan

Indexed keywords

PROTEOGLYCAN; SYNDECAN; TUMOR MARKER;

ARTICLE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; PROTEOGLYCANS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SYNDECAN-1; SYNDECANS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032903593     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690088     Document Type: Article

References (34)

1. Benasso M, Bonelli L, Numico G, Corvo R, Sanguineti G, Rosso R, Vitale V and Merlano M (1997) Treatment with cisplatin and fluorouracil alternating with radiation favourably affects prognosis of inoperable squamous cell carcinoma of the head and neck: results of a multivariate analysis on 273 patients. Ann Oncol 8: 773-779
2. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL and Lose E (1992) Biology of syndecans. Annu Rev Cell Biol 8: 365-393
3. Bundgaard T, Sørensen FB, Gaihede M, Søgaard H and Overgaard J (1992) Stereometric, histopathologic, flow cytometric and clinical parameters in the prognostic evaluation of 74 patients with intraoral squamous cell carcinomas. Cancer 70: 1-13
4. Cook DM, Hinkes MT, Bernfield M and Rausher FL III (1997) Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. Oncogene 13: 1789-1799
5. Elenius K, Salmivirta M, Inki P, Mali M and Jalkanen M (1990) Binding of human syndecan to extracellular matrix proteins. J Biol Chem 29: 17837-17843
6. Elenius K, Vainio S, Laato M, Salmivirta M, Thesleff I and Jalkanen M (1991) Induced expression of syndecan in healing wounds. J Cell Biol 114: 585-595
7. Elenius K, Määttä A, Salmivirta M and Jalkanen M (1992) Growth factors induce 3T3 cells to express bFGF-binding syndecan. J Biol Chem 25: 6435-6441
8. El-Sayed S and Nelson N (1996) Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 14: 838-847
9. Hayashi K, Hayashi M, Jalkanen M, Firestone JH, Trelstad RL and Bernfield M (1987) Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissue. A light and electron microscopic study. J Histochem Cytochem 35: 1079-1088
10. Horiot JC, Le Fur R, N'guyen T, Chenal C, Schraub S, Alfonsi S, Gardani G, Van Den Bogaert W, Danzak S, Bolla M, Van Glabbeke M and De Pauw M (1992) Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25: 231-241
11. Inki P, Stenbäck F, Talve L and Jalkanen M (1991) Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Am J Pathol 139: 1333-1340
12. Inki P, Kujari H and Jalkanen M (1992) Syndecan in carcinomas produced from transformed epithelial cells in nude mice. Lab Invest 66: 314-323
13. Inki P, Larjava H, Haapasalmi K, Miettinen H, Grenman R and Jalkanen M (1994a) Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes. Eur J Cell Biol 63: 43-51
14. Inki P, Joensuu H, Grenman R, Klemi P and Jalkanen M (1994b) Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer 70: 319-323
15. Jalkanen M, Elenius K and Rapraeger A (1993) Syndecan: regulator of cell morphology and growth factor action at the cell-matrix interface. Trends Glycosci Glycotechn 5: 107-120
16. Koda J, Rapraeger A and Bernfield M (1985) Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens. J Biol Chem 260: 8157-8162
17. Kojima T, Scworak NW and Rosenberg RD (1992) Molecular cloning and expression of two distinct cDNAs encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line. J Biol Chem 267: 4870-4877
18. Leppä S, Mali M, Miettinen H and Jalkanen M (1992) Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci USA 89: 932-936
19. Liotta LA, Rao CN and Wewer UM (1986) Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 55: 1037-1051
20. Liu K, Kasper M, Bierhaus A, Langer S, Peterson I, Muller M and Trott KR (1997) Differential expression of CD44 and CD44v10 proteins and syndecan in normal and irradiated mouse epidermis. Histochem Clee Biol 107: 159-167
21. Pera E, Moreno A and Galino L (1986) Prognostic factors in laryngeal carcinoma. Cancer 58: 928-934
22. Pulkkinen JO, Penttinen M, Jalkanen M, Klemi P and Grenman R (1997) Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol (Stockh) 117: 312-315
23. Rapraeger A and Bernfield M (1983) Heparan sulfate proteoglycans from mouse mammary epithelial cells. A putative membrane proteoglycan associates quantitatively with lipid vesicles. J Biol Chem 258: 3632-3636
24. Ruoslahti E (1989) Proteoglycans in cell regulation. J Biol Chem 264: 13369-13372
25. Salmivirta M, Elenius K, Vainio S, Hofer U, Chiquet-Erismann R, Thesleff I and Jalkanen M (1991) Syndecan from embryonic tooth mesenchyme binds tenascin. J Biol Chem 266: 7733-7739
26. Salmivirta M, Rauvala H, Elenius K and Jalkanen M (1992) Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res 200: 444-451
27. Salmivirta M, Mali M, Heino J, Hermonen J and Jalkanen M (1994) A novel laminin-binding form of syndecan-1 (cell surface proteoglycan) produced by syndecan-1 cDNA-transfected NIH-3T3 cells. Exp Cell Res 215: 180-188
28. Saunders S and Bernfield M (1988) Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor on interstitial matrix. J Cell Biol 106: 423-430
29. Shanmugaratnam K and Sobin LH (eds) (1978) Histological Typing of Upper Respiratory Tract Tumours, pp. 14-33. WHO: Geneva
30. Sun X, Mosher DF and Rapraeger A (1989) Heparan sulfate-mediated binding of epithelial cell surface proteoglycan to thrombospondin. J Biol Chem 264: 2885-2889
31. Thesleff I, Jalkanen M, Vainio S and Bernfield M (1988) Cell surface proteoglycan expression correlates with epithelial-mesenchymal interaction during tooth morphogenesis. Dev Biol 129: 565-572
32. Vainio S, Lehtonen E, Jalkanen M, Bernfield M and Saxen L (1989) Epithelial -mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, in the developing kidney. Dev Biol 134: 382-391
33. Weinstein RS, Merk FB and Alroy J (1976) The structure and function of intercellular junctions in cancer. Adv Cancer Res 23: 25-33
34. Wiernik G, Millard PR and Haybittle JL (1991) The predictive value of histological classification into degrees of differentiation of squamous cell carcinoma of the larynx and hypopharynx compared with the survival of patients. Histopathology 19: 411-417